BURRELL INTERNATIONAL GROUP LLC

Lobbying for CELLPHIRE, INC. · Biotechnology Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $40,000.00 income · posted Jul 19, 2026

Lobbying activity 1

Health Issues

Pandemic and All Hazard Preparedness Act, FY27 LHHS and Defense Appropriations for next generation blood products; FY27 NDAA, FY27 LHHS and FY27 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.